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Abstract 
Background: Partial bypass of the GI tract may promote weight loss by decreased absorption of nutrients and 
changes in incretins. The aim of the study was to evaluate the safety and efficacy of performing a side-to-side 
duodeno-ileal anastomosis.
Methods: Seven 40–50 kg female Yorkshire pigs were allocated to a duodeno-ileal anastomosis (DIA), and were 
compared to a control group (SHAM). Swine’s weights were followed for 56 days. Gastroscopies were also performed 
at 28 days. Blood samples were also taken at regular intervals (CBC and Basic biochemistry profiles). At autopsy, gross 
changes and histological changes of the liver, duodenum and ileum samples were performed.
Results: While the SHAM group gained 33.2 % more weight at 56 days, the DIA group had shown a weight loss of 
−6.8 %, for a difference of 40.0 % between the 2 groups (p < 0.05). One pig developed an incisional hernia. Gastros-
copies demonstrated normal healing without ulceration or inflammation at 28 days. Histological examination of the 
anastomosis at 56 days showed normal and smooth healing, with absence of liver toxicity.
Conclusion: In this porcine model with short follow-up, a side-to-side duodeno-ileal anastomosis provided excellent 
weight loss without apparent nutritional or grossly aberrant histological changes.
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Background
In the purest form of malabsorptive surgery for weight 
loss, the jejunoileal bypass (JIB), one of the earliest types 
of bariatric surgery, was introduced with its many varia-
tions, four and five decades ago. The JIB was performed 
end-to-side, with the proximal thirty centimeters jeju-
num anastomosed to the distal 15 cm of ileum, or end-
to-end, with bypassed small bowel derived end-to-side 
to the colon. In both instances more than 90 % of small 
intestine was bypassed, unexcised, excluding it from the 
alimentary channel leaving a blind end, causing bacterial 
overgrowth.
Excellent weight loss and complete resolution of type-2 
diabetes mellitus were reported after JIB [1, 2]. However, 
a variety of complications related to JIB were reported, 
including: hypoalbuminemia, hypokalemia, hypocalce-
mia, hyperbilirubinemia, migratory polyarthralgias, cal-
cium oxalate urinary calculi, and elevated liver enzymes 
levels and deaths due to liver failure [3, 4]. Diarrhea and 
flatulence were common. The excluded intestinal seg-
ment was associated with various problems, including 
intussusceptions; bypass enteritis, and colonic pseudo-
obstruction. Other authors reported that the risk of pro-
gressive liver disease existed indefinitely and that ongoing 
careful follow-up was necessary [5, 6].
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However, when a 90 % small bowel resection in germ 
free rats is compared to a 90 % small bowel bypass, the 
resected animals have remained with normal liver his-
tology after a prolonged period. This means that any 
blind limb is possibly responsible for liver insufficiency. 
Therefore the development of a new surgical malab-
sorptive procedure should not involve any blind seg-
ment [7]. A model of partial malabsorptive bypass is 
constructed with a side-to-side anastomosis between 
the 3rd portion of the duodenum and last 50 cm of the 
ileum (anatomically in close proximity) Figs.  1, 2, 3, 
allowing a partial flow of nutrients to move in the proxi-
mal jejunum for normal mineral absorption and caloric 
intake, while a portion is bypassed into the distal ileum, 
causing a decreased absorption resulting in weight loss. 
Since both limbs have flow, bacterial overgrowth is of 
a lesser concern theoretically comparable to Roux-en-
Y gastric bypass (Fig.  4). To perform this anastomo-
sis, a compression anastomotic device was used for its 
simplicity.
Compression anastomotic devices for the perfor-
mance of gastrointestinal anastomosis have been avail-
able for more than a century and used extensively in 
colon surgery in its resorbable form, and more recently 
simulating a commercial end-to-end anastomotic device 
[8–10].
The aim of the study was to evaluate the safety and effi-
cacy of using a compression anastomotic device to create a 
permanent anastomosis between the small bowel and duo-
denum. Also, to evaluate the effect of a side-to-side duo-
deno-ileal anastomosis on weight loss, in the short term.
Fig. 1 Position of the right transverse colon overlying the 3rd and 
fourth portions of the duodenum, with distal ileum lying in close 
proximity
Fig. 2 Endotract TM device implanted between the lower side of the 
3rd portion of the duodenum and upper side of distal ileum, by open 
enterotomies
Fig. 3 After 7–10 days of tissue compression, the Endotract TM 
device has passed with bowel transit, leaving a permanent side-to-
side duodeno-ileal anastomosis
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Methods
The animal protocol was approved by the institutional 
Animal care and use Committee (IACUC) of American 
Preclinical Services, LLC (APS) facility licensed with the 
United States Department of Agriculture. We used 7 
Yorkshire pigs,  >2  months old, weighing approximately 
40–60 kg, housed individually. The porcine diet consisted 
of a fixed formula certified by the manufacturer to be 
free of environmental contaminants; tap water was given 
ad libitum.
Blood samples were taken for minimal hematology 
parameters (red blood cell count, hemoglobin, hema-
tocrit, platelet count, white blood cell count and differ-
ential), minimal serum biochemistry parameters (Urea 
nitrogen (BUN), creatinin, total protein, albumin, aspar-
tate aminotransferase (AST), gamma glutamyltransferase 
(GGT), glucose, sodium, potassium, chloride, calcium, 
phosphorus, bicarbonate). Prior to surgery, animals have 
been administered a 3  days bowel prep with 2  l/day of 
Golitely (PEG-3350, Braintree Laboratories, Inc., Brain-
tree, MA, USA) and Ensure (Abbott Nutrition, Colum-
bus, OH, USA) to cleanse the colon, and were fasted the 
night before except for water. Preoperative medication 
included; Telazol 2–8  mg/kg for anesthesia induction 
(Tiletamine HCl and Zolazepram HCl, Animal Health-
care, Wyeth (now Pfizer, Inc.), Fort Dodge, IA), Xylazine 
2–8  mg/kg (Bayer Healthcare, Leverkusen, Germany) 
for anesthesia induction, Buprenorphine 0.01–0.05  mg/
kg for pain management (Buprenex, Reckitt & Col-
man Pharmaceuticals, Inc., Richmond, VA, USA), and 
Oxytetracycline (long acting) 20 mg/kg (Hebei New Cen-
tury Pharmaceutical Co., Ltd., Hebei, China)for infection 
prophylaxis.
Four animals were allocated to a side-to-side duodeno-
ileostomy with the compression anastomotic device 
and 3 to a control group. After endotracheal intubation, 
anesthesia was maintained with isoflurane in 100  % O2 
and propofol at 2–8  mg/kg, with an intravenous Ring-
ers’ lactate solution at 2–10  ml/kg/h. After laparotomy 
with a 25 cm upper midline incision, a duodenotomy of 
approximately 2.5 cm was created anterior to admit the 
proximal part of the compression anastomotic device, 
and an ileotomy approximately 50  cm from the ileoce-
cal valve was made to insert the distal part compression 
anastomotic device. The anastomosis was performed by 
compression of both parts away from the duodenotomy 
and ileotomy (Fig. 2). Both openings of the small bowel 
were closed with a running suture of 3-0 Vicryl (Polyglac-
tin-910, Ethicon, Cincinnati, OH). The control group had 
both enterotomies closed with a running suture only. A 
liver biopsy was also performed by a wedge. The abdomi-
nal wound is closed with Vicryl 1-0 for fascia and 3-0 for 
skin.
During recovery in the pen and postoperative period, 
the animals received Buprenorphine 0.01–0.05 mg/kg IM 
as needed, ketoprofen 1.8–2.2 mg/kg IM daily for the first 
3 days (Ketofen, Fort Dodge Animal Health, Fort Dodge, 
IA, USA), Prilosec 20 mg once daily (Omeprazole, Astra-
Zeneca, Wilmington, DE, USA), and Oxytetracycline 
(long acting) 18–25 mg/kg IM on day 3. During the first 
24 h, the animals were allowed to drink water, and after-
wards soft food was introduced to gradually progress to a 
normal solid diet over 10 days. Elimination of the device 
was recorded, including signs of infection. Blood samples 
were taken at day 0, 3 and 56.
On Day 28, a gastroscopy (Olympus, GIF-2T20, 
11.2  mm diameter) was performed under general anes-
thesia, using a similar protocol, and photographs were 
obtained of the anastomosis, and nearby intraluminal 
organs, to assess patency, diameter, and degree of inflam-
mation and presence of macroscopic abnormalities. An 
attempt was made to measure the intestinal shunting 
from the procedure by introducing approximately 25 
radiopaque doughnut-type markers (Sitzmark, Konsyl 
Pharmaceutis, Inc., TX, USA) in the proximal stomach 
for a gastrointestinal transit study, by taking abdominal 
x-rays every 2 h for 6 h.
At 8 weeks, euthanasia and necropsy of the abdominal 
cavity is performed. Samples of the liver were taken at the 
time of the anastomotic procedure (pre-sample) and at 
necropsy (left medial liver lobe, post-sample) and immer-
sion-fixed in 10 % neutral buffered formalin (NBF). The 
gastrointestinal tract was rinsed with water to remove 
Fig. 4 Comparison of digestive flow between a gastric bypass and 
a side-to-side duodeno-ileal anastomosis. Alimentary flow and bili-
opancreatic secretions are mixing in a Y channel (100–150 cm in mid 
jejunum) in a gastric bypass, while in a side-to-side duodeno-ileal 
anastomosis, the alimentary flow is divided between a regular jejuno-
ileal channel and a distal ileal channel, and biliopancreatic secretions 
are mixing in the proximal duodenum
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food content and images were taken of each excised 
anastomotic site. Additionally, a sample of the right glu-
teus maximus was procured from each animal. All tissue 
samples were immersion-fixed in 10 % NBF. Two sections 
from each anastomotic site were trimmed, sections of 
pre- and post-anastomosis lever samples, and a section of 
right gluteus maximus skeletal muscle were taken for his-
tological processing. The sections were placed in labeled 
cassettes and tissues were processed through a graded 
series of alcohols, embedded in paraffin, cut with a rotary 
microtome to approximately 5 µm in thickness, mounted 
on microscopic slides, and stained with hematoxylin and 
eosin (H & E) and Masson’s trichrome stains. American 
Preclinical Services (APS) sent the digital images taken at 
necropsy, completed gross pathology forms, trim sheets, 
and microscopic slides to a board-certified veterinary 
pathologist for independent interpretation. The sec-
tions of the anastomotic sites were evaluated for healing 
response and the presence of inflammation, infection, or 
dehiscence at the site of apposition.
Results
At 28  days post surgery all pigs are healthy, with good 
appetite, eating the proposed diet with normal feces. 
However, one pig had developed a small, external inci-
sional hernia, which had to be corrected. At 28 days duo-
denoscopy of all animals showed a widely patent healed 
side-to-side duodeno-ileal anastomosis, with proximal 
ileum on the right and distal ileum on the left (Fig. 5a, b). 
The gastroscope was able to pass through the anastomo-
sis, in all limbs. There was no evidence of gross ulcera-
tions in all parts of the duodenum, nor in the ileum. There 
was no visible inflammation either. The anastomosis itself 
revealed a smooth transition between both mucosae. 
Since the pigs had been fasting and mostly bilious fluids 
with saponification from the air insufflations was visible. 
We were not successful in determining various gastro-
intestinal transit times from both limbs, as the transit 
of markers were too slow (the majority remained in the 
stomach during the study period).
Weight progression in both the DI animals and con-
trols were recorded weekly and plotted for comparison. 
In fact for better understanding of the progression, the 
mean percentage of weight change from baseline in ani-
mals that had a side-to-side duodeno-ileal anastomosis 
(study group) versus sham controls, over time in days was 
projected (Fig. 6). At 56 days, control animals had gained 
33.2  % of weight, while study animals had lost 6.8  % of 
weight.
All Blood tests are reported in Table  1 and 2. Mean 
values for hematological profiles at baseline, day 3 and 
56 shows a decline in RBC count (−21  %), hemoglobin 
(−15  %), hematocrit (−19  %) and increase in platelet 
counts (+60  %) and WBC counts (+16  %), at 56  days 
compared to baseline. Equally, mean values of serum bio-
chemical profiles at baseline, day 3 and 36 are presented 
in Table 2. After a slight increase (+33 %) in serum glu-
cose at day 3, presumably from stress response after 
surgery, the mean value returns within normal range at 
56 days. There is a notable decrease in serum total pro-
tein and albumin at 56  days by 23 and 25  %, attribut-
able to a fixed diet. Equally, the BUN has increased by 
threefold at 56 days. Nitrogen loss maybe attributable to 
inadequate intake of calories from a restricted diet and 
decreased absorption from bypass of the GI tract. A slight 
and subtle change of serum calcium (−11 %) and phos-
phorus (−17 %) is observed at 56 days, but within normal 
range, and may parallel the decrease in serum proteins. 
The serum potassium, sodium, chloride and bicarbo-
nate remained within normal range. The only serum liver 
enzyme measured remained constantly normal.
Fig. 5 a Duodenoscopy of the 3rd portion of the duodenum, 
showing a healed side-to-side duodeno-ileal anastomosis, with 
proximal ileum on the right and distal ileum on the left of the figure. b 
Duodenoscopy of the 3rd portion of the duodenum from a different 
animal, showing a healed side-to-side duodeno-ileal anastomosis, 
with distal duodenum on the far right of the figure
Fig. 6 Graph of % of weight change in animals that had a side-to-
side duodeno-ileal anastomosis (study group) versus sham controls, 
over time in days. At 56 days, control animals had gained 33.2 % of 
weight, while study animals had lost 6.8 % of weight
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At necropsy, general flimsy adhesions were encoun-
tered near the anastomosis; the liver had a normal mac-
roscopic appearance. Each gastroduodenal areas were 
harvested for measurements and histological sampling. 
Macroscopic external view of a side-to-side duodeno-
ileal anastomosis revealed a smooth surface serosal appo-
sitions (Fig.  7), and inside the anastomosis could admit 
the index finger (Fig.  8a), and once this duodenoileal 
anastomosis was opened along its longitudinal axis, a 
smooth surface was revealed (Fig. 8b).
All layers of the intestine were well healed with good 
apposition of the mucosa and muscular layers of the 
duodenum and ileum. A variable amount of fibrous con-
nective tissue was noted in the muscular layers of the 
two apposed edges of the intestine and extended into 
the surrounding muscle bundles. The muscle layers at 
the anastomotic site appeared to align (Figs  9, 10). The 
vasculature throughout the intestinal sections appeared 
normal with no evidence of thrombus formation or 
occlusion. Mild serosal edema was seen and serosa ves-
sels appeared prominent with some perivascular edema 
noted. No evidence of infection, inflammation, or dehis-
cence was noted at any of the anastomotic sites. Two (2) 
of the four (4) post-liver samples taken were considered 
within normal limits (WNL) and the other two (2) of 
four (4) samples showed subtle changes of hepatocellu-
lar swelling with glycogen accumulation (Fig.  11). Simi-
lar microscopic changes of glycogen accumulation can 
also be seen during various stages of fasting in animals. 
No evidence of muscle fiber vacuolization, loss, inflam-
mation, fatty infiltration or increased fibrous connec-
tive tissue deposition was seen in any of muscle sections 
examined.
Discussion
The use of a new compressive device for GI anastomo-
sis allowed a safe and effective creation of an anastomosis 
between two portions of the small bowel. The anastomo-
sis created was robust, healthy and permanent, which 
facilitated a partial diversion of nutrient flow and thus 
altered nutrients absorption, causing effective weight 
loss in this porcine model with short follow-up. A side-
to-side duodeno-ileal anastomosis provided excellent 
weight loss, without diarrhea or grossly aberrant histo-
logical changes, especially in the liver. However, a nota-
ble decline in serum total protein and albumin levels (and 
elevated BUN) may point towards inadequate protein/
calorie absorption. In the absence of proper nitrogen 
balance measurements, resting energy expenditure, one 
cannot conclude that inadequate intake resulted in this 
early phenomenon, especially taking into account the 
energetic and protein needs to heal a midline laparotomy 
Table 1 Mean values of hematological profiles at baseline, 
day 3 and 56
WBC white blood count
Time after duodeno-ilial anastomosis
Baseline Day 3 Day 56
RBC count 6.46 6.92 5.09
Hemoglobin (g/DL) 11.08 12.05 9.40
Hematocrit (%) 34.65 36.48 28.10
Platelet count 280.25 305.50 448.50
WBC count 14.55 16.83 16.85
Table 2 Mean values of  serum biochemical profiles 
at baseline, day 3 and 56
AST alamine serum trasnferase, N nitrogen, GT glutamine transferase
Time after duodenum-ileal anastomosis
Baseline Day 3 Day 56
Glucose 75.75 101.25 88.50
AST 35.25 29.00 39.25
Total protein 6.53 6.40 5.05
Albumin 3.45 3.30 2.58
Urea N 5.00 8.75 15.00
Creatinine 1.38 1.30 1.15
Phosphorous 7.20 7.00 6.00
Calcium 10.23 9.60 9.10
Sodium 141.75 140.25 136.25
Potassium 3.65 3.80 4.25
Chloride 102.00 98.00 103.25
Bicarbonate 27.75 29.00 26.75
Gamma-GT 26.75 24.25 21.25
Fig. 7 Macroscopic external view of a side-to-side duodeno-ileal 
anastomosis at 56 days
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and 2 enterotomies. It is also possible that if the animal 
had access to an ad  libitum diet that serum protein and 
albumin levels would have been maintained.
In the real clinical world, humans have free access to 
nutrients, and are provided with protein supplementation 
and nutritional counseling after surgery. It is expected 
that any malabsorptive procedure, must include these 
components and serial serum levels of protein, albumin, 
minerals, fat soluble vitamins and liver enzymes, similarly 
to gastric bypass, biliopancreatic diversion with or with-
out duodenal switch must be carried out at regular inter-
vals. Equally remarkable, is that the bypassed intestine 
in the pig, is greater with (97  % bypass, 50  cm from 18 
meters) a ratio of 1: 36 when compared to humans (90 % 
bypass, 50  cm from 5 meters) with a ratio of 1:10 [11]. 
Therefore, this phenomenon may be seen less in humans.
Recent literature still appears on jejuno-ileal bypass 
and its’ modifications. Recently, Fazel et  al. have 
reported a successful consecutive series of forty-three 
patients who underwent a modified jejunoileal bypass 
where the defunctionalyzed limb was anastomosed to 
the gall bladder and cecum, resulting in a loss of 43 kg 
(or 15 kg/m2 of BMI) at 5 years, without changes in liver 
histology [12].
Fig. 8 a Macroscopic luminal view (from the ileum side) of a side-to-side duodeno-ileal anastomosis at 56 days. b Macroscopic luminal view of a 
longitudinal opening of a side-to-side duodeno-ileal anastomosis at 56 days
Fig. 9 a, b Longitudinal section through the well healed duodenal-ileal anastomotic site. Note the apposition of all intestinal layers. The duodenal 
mucosa is contiguous with the ileal mucosa. Fibrous connective tissue (blue in trichrome stain) separates the muscle layers of the two portions of 
the intestine. The serosa appears slightly edematous. The lymphatics in the ileal submucosa appear dilated. There is no evidence of infection, inflam-
mation or dehiscence at the anastomotic site. a H & E stain; b Masson’s trichrome stain. Both images ×20 magnification
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One of the main reason why jejunoileal bypass was 
abandoned were reports of deaths from liver failure. 
Meinhardt and colleagues have followed carefully 50 con-
secutive patients who underwent JIB, in which liver biop-
sies were performed intraoperatively in 41 patients and in 
follow-up of 31 patients. With good weight loss at a mean 
of 67 months, no deaths occurred from liver failures and 
liver histology was stable [5].
The team of Rosina on 49 patients extensively studied 
bacterial overgrowth. Only 45  % of patients had some 
colonic micro flora in the excluded limb of jejunoileal 
bypass. The colonization appeared to correlate with 
clinical symptoms of bloating, migratory arthralgia, and 
rashes and skin lesions. But conversely, the positive cul-
tures were not always associated with symptoms. No spe-
cific bacteriology was associated with this phenomenon. 
According to Rosina, the “success of an intestinal bypass 
may depend not only on anatomic and functional adap-
tation to the new, surgically created conditions, but also 
to the attainment of microbiological equilibrium in the 
intestinal ecosystem” [13].
Riordan et al. have reported that bacterial overgrowth 
does not necessarily correlates with neither liver damage 
nor increased intestinal permeability in human subjects 
[14].
The main advantage of a duodeno-ileostomy would be 
the fast ileal stimulation, causing an early incretin release 
and offering a potential tool for the resolution of type-2 
diabetes. Recent hypothesis concerning the resolution of 
type-2 diabetes after weight loss surgery seems to point 
out that distal bowel stimulation may promote the pro-
duction of glucagon-like peptide-1 (GLP-1) from the 
ileal and colonic L cells. There has been some evidence 
of this phenomenon when ileal transposition has been 
performed in Goto-Kakizaki type-2 diabetic rats [15]. 
Mason had proposed an ileal transposition to promote 
the early release of GLP-1 for the cure of type-2 diabe-
tes [16]. Although we did not measure this hormone in 
pigs after duodeno-ileostomy, we postulate that an early 
release of GLP-1 will be a main endocrine feature of this 
operation.
Peptide YY (PYY) is also released from the distal small 
bowel endocrine cells is released in the circulation after 
a fatty meal, and PYY seemed to appear in the ileal 
lumen at greater concentration when glucose is used 
predominantly in the diet [17]. In fact when oleic acid 
is infused into the duodenum, PYY is released approxi-
mately 10–30 min after. The site of production of circu-
lating PYY appears to be the ileum, colon and rectum. 
If an ileocolectomy is performed, an abolished produc-
tion of PYY to intraduodenal stimulation of oleic acid is 
Fig. 10 a–d Longitudinal sections through the well healed duode-
nal-ileal anastomotic site. It appears that all layers of the intestine are 
apposed (muscular layers not closely apposed) although only a small 
portion of the ileal mucosa is present in the first second (a, b) and 
the mucosa overlying the anastomotic site is absent in the second 
section (c, d). Abundant fibrous connective tissue (blue in trichrome 
stain) separates the muscle layers of the two portions of the intestine. 
The serosa appears slightly edematous and serosal vessels appear 
prominent with perivascular edema. There is no evidence of infection, 
inflammation or dehiscence at the anastomotic site. All images—×20 
magnification. a, c H & E stain; b, d Masson’s trichrome stain
Fig. 11 Liver histology at 56 days. Subtle centrilobular hepatocel-
lular swelling and granularity (consistent with glycogen deposition) is 
noted in this animal. H & E stain, ×100 magnification
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observed. This release is not mediated by neural pathway, 
but solely from endocrine nature [18].
In turn, the increasing concentration of intravenous 
infusion of PYY reduces the glucose stimulated insulin 
release. This suggests that PYY affects the Beta-cell func-
tion by a possible autonomic regulation [19]. Similarly, 
we are postulating that an early ileal release of PYY will 
occur after a side-to-side duodeno-ileostomy, and could 
be one hypothesis behind the effective weight loss seen in 
these animals.
Conclusion
In this porcine model with short follow-up, a side-to-side 
duodeno-ileal anastomosis provided excellent weight loss 
without apparent nutritional or grossly aberrant histo-
logical changes. This intervention is likely to cause weight 
loss by numerous mechanisms including decreased food 
absorption and decreased satiety from endocrine stimu-
lation [20, 21].
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